SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Intuitive Surgical Inc. – ‘10-Q’ for 9/30/20 – ‘EX-31.2’

On:  Monday, 10/19/20, at 5:22pm ET   ·   For:  9/30/20   ·   Accession #:  1035267-20-166   ·   File #:  0-30713

Previous ‘10-Q’:  ‘10-Q’ on 7/23/20 for 6/30/20   ·   Next:  ‘10-Q’ on 4/21/21 for 3/31/21   ·   Latest:  ‘10-Q’ on 4/19/24 for 3/31/24   ·   5 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

10/19/20  Intuitive Surgical Inc.           10-Q        9/30/20   77:10M

Quarterly Report   —   Form 10-Q
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.06M 
 2: EX-3.1      Articles of Incorporation/Organization or Bylaws    HTML     61K 
 3: EX-31.1     Certification -- §302 - SOA'02                      HTML     28K 
 4: EX-31.2     Certification -- §302 - SOA'02                      HTML     28K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     25K 
 6: EX-32.2     Certification -- §906 - SOA'02                      HTML     25K 
13: R1          Cover Page                                          HTML     75K 
14: R2          Condensed Consolidated Balance Sheets (Unaudited)   HTML    100K 
15: R3          Condensed Consolidated Balance Sheets               HTML     40K 
                (Parenthetical)                                                  
16: R4          Condensed Consolidated Statements of Comprehensive  HTML     88K 
                Income (Unaudited)                                               
17: R5          Condensed Consolidated Statements of Cash Flows     HTML    102K 
                (Unaudited)                                                      
18: R6          Description of the Business                         HTML     26K 
19: R7          Summary of Significant Accounting Policies          HTML     70K 
20: R8          Financial Instruments                               HTML    225K 
21: R9          Balance Sheet Details and Other Financial           HTML     70K 
                Information                                                      
22: R10         Revenue and Contract Acquisition Costs              HTML     93K 
23: R11         Leases                                              HTML     47K 
24: R12         Goodwill and Intangible Assets                      HTML     69K 
25: R13         Contingencies                                       HTML     36K 
26: R14         Stockholders' Equity                                HTML    340K 
27: R15         Share-Based Compensation                            HTML     98K 
28: R16         Income Taxes                                        HTML     30K 
29: R17         Net Income Per Share                                HTML     51K 
30: R18         Summary of Significant Accounting Policies          HTML     69K 
                (Policies)                                                       
31: R19         Summary of Significant Accounting Policies          HTML     53K 
                (Tables)                                                         
32: R20         Financial Instruments (Tables)                      HTML    230K 
33: R21         Balance Sheet Details and Other Financial           HTML     77K 
                Information (Tables)                                             
34: R22         Revenue and Contract Acquisition Costs (Tables)     HTML    104K 
35: R23         Leases (Tables)                                     HTML     67K 
36: R24         Goodwill and Intangible Assets (Tables)             HTML     65K 
37: R25         Stockholders' Equity (Tables)                       HTML    344K 
38: R26         Share-Based Compensation (Tables)                   HTML    103K 
39: R27         Net Income Per Share (Tables)                       HTML     51K 
40: R28         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     39K 
                Additional Information (Details)                                 
41: R29         SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES -        HTML     51K 
                Amortized Cost Basis by Year of Origination and                  
                Credit Quality Indicator (Details)                               
42: R30         FINANCIAL INSTRUMENTS - Summary of Cash and         HTML     91K 
                Available-For-Sale Securities (Details)                          
43: R31         FINANCIAL INSTRUMENTS - Summary of Contractual      HTML     41K 
                Maturities of Cash Equivalents and                               
                Available-For-Sale Investments (Details)                         
44: R32         FINANCIAL INSTRUMENTS - Summary of Equity           HTML     47K 
                Investment Activity (Details)                                    
45: R33         FINANCIAL INSTRUMENTS - Derivative Instruments      HTML     32K 
                Used to Hedge against Balance Sheet Foreign                      
                Currency Exposures (Details)                                     
46: R34         FINANCIAL INSTRUMENTS - Gross Notional Amounts for  HTML     37K 
                Outstanding Derivatives (Details)                                
47: R35         BALANCE SHEET DETAILS AND OTHER FINANCIAL           HTML     32K 
                INFORMATION - Inventory (Details)                                
48: R36         BALANCE SHEET DETAILS AND OTHER FINANCIAL           HTML     34K 
                INFORMATION - Prepaids and Other Current Assets                  
                (Details)                                                        
49: R37         BALANCE SHEET DETAILS AND OTHER FINANCIAL           HTML     34K 
                INFORMATION - Other Accrued Liabilities -                        
                Short-term (Details)                                             
50: R38         BALANCE SHEET DETAILS AND OTHER FINANCIAL           HTML     32K 
                INFORMATION - Other Long-term Liabilities                        
                (Details)                                                        
51: R39         BALANCE SHEET DETAILS AND OTHER FINANCIAL           HTML     27K 
                INFORMATION - Supplemental Cash Flow Information                 
                (Details)                                                        
52: R40         REVENUE AND CONTRACT ACQUISITION COSTS - Revenue    HTML     45K 
                Disaggregated by Types and Geography (Details)                   
53: R41         REVENUE AND CONTRACT ACQUISITION COSTS -            HTML     36K 
                Additional Information (Details)                                 
54: R42         REVENUE AND CONTRACT ACQUISITION COSTS - Summary    HTML     27K 
                of Contract Assets and Liabilities (Details)                     
55: R43         REVENUE AND CONTRACT ACQUISITION COSTS -            HTML     28K 
                Sales-type and Operating Lease Revenue (Details)                 
56: R44         LEASES - Lease Receivables (Details)                HTML     37K 
57: R45         LEASES - Schedule of Contractual Maturities of      HTML     38K 
                Gross Lease Receivables (Details)                                
58: R46         Intangible Assets, Goodwill and Other (Details)     HTML     73K 
59: R47         GOODWILL AND INTANGIBLE ASSETS - Schedule of        HTML     30K 
                Summary of Changes in Goodwill (Details)                         
60: R48         GOODWILL AND INTANGIBLE ASSETS - Schedule of        HTML     38K 
                Intangible Assets (Details)                                      
61: R49         GOODWILL AND INTANGIBLE ASSETS - Schedule Of        HTML     38K 
                Estimated Future Amortization Expense Of                         
                Intangible Assets (Details)                                      
62: R50         STOCKHOLDERS' EQUITY - Schedule of Stockholders     HTML     93K 
                Equity (Details)                                                 
63: R51         STOCKHOLDERS' EQUITY - Schedule of Share            HTML     36K 
                Repurchase Activities (Details)                                  
64: R52         STOCKHOLDERS' EQUITY - Stock Repurchase Program     HTML     33K 
                (Details)                                                        
65: R53         STOCKHOLDERS' EQUITY - Components of Accumulated    HTML     95K 
                Other Comprehensive Income, Net of Tax (Details)                 
66: R54         SHARE-BASED COMPENSATION - Additional Information   HTML     49K 
                (Details)                                                        
67: R55         SHARE-BASED COMPENSATION - Summary of Stock Option  HTML     44K 
                Activity Under All Stock Plans (Details)                         
68: R56         SHARE-BASED COMPENSATION - Summary of RSU Activity  HTML     47K 
                (Details)                                                        
69: R57         SHARE-BASED COMPENSATION - Stock-Based              HTML     42K 
                Compensation Expense (Details)                                   
70: R58         SHARE-BASED COMPENSATION - Schedule of Estimated    HTML     39K 
                Fair Value of Option Using Black-Scholes Option                  
                Pricing Model, Weighted Average Assumptions                      
                (Details)                                                        
71: R59         INCOME TAXES - Additional Information (Details)     HTML     40K 
72: R60         NET INCOME PER SHARE - Computation of Basic and     HTML     46K 
                Diluted Net Income Per Share (Details)                           
73: R61         NET INCOME PER SHARE - Additional Information       HTML     25K 
                (Details)                                                        
75: XML         IDEA XML File -- Filing Summary                      XML    138K 
12: XML         XBRL Instance -- isrg-20200930_htm                   XML   3.28M 
74: EXCEL       IDEA Workbook of Financial Reports                  XLSX     95K 
 8: EX-101.CAL  XBRL Calculations -- isrg-20200930_cal               XML    270K 
 9: EX-101.DEF  XBRL Definitions -- isrg-20200930_def                XML    485K 
10: EX-101.LAB  XBRL Labels -- isrg-20200930_lab                     XML   1.52M 
11: EX-101.PRE  XBRL Presentations -- isrg-20200930_pre              XML    871K 
 7: EX-101.SCH  XBRL Schema -- isrg-20200930                         XSD    147K 
76: JSON        XBRL Instance as JSON Data -- MetaLinks              341±   540K 
77: ZIP         XBRL Zipped Folder -- 0001035267-20-000166-xbrl      Zip    323K 


‘EX-31.2’   —   Certification — §302 – SOA’02


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Document  
EXHIBIT 31.2

Certification of Chief Financial Officer
Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002
I, Marshall L. Mohr, certify that:
1.I have reviewed this quarterly report on Form 10-Q of Intuitive Surgical, Inc.;
2.Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;
3.Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;
4.The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:
a)Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;
b)Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;
c)Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and
d)Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and
5.The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):
a)All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and
b)Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.
Date: October 19, 2020
By:
/S/ MARSHALL L. MOHR
Marshall L. Mohr
Executive Vice President and Chief Financial Officer



Dates Referenced Herein

This ‘10-Q’ Filing    Date    Other Filings
Filed on:10/19/20None on these Dates
For Period end:9/30/20
 List all Filings 


4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 1/31/24  Intuitive Surgical Inc.           10-K       12/31/23  106:13M
 2/10/23  Intuitive Surgical Inc.           10-K       12/31/22  105:14M
 2/03/22  Intuitive Surgical Inc.           10-K       12/31/21  105:14M
 2/10/21  Intuitive Surgical Inc.           10-K       12/31/20  105:13M


1 Previous Filing that this Filing References

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/28/20  Intuitive Surgical Inc.           8-K:5,7,9   4/23/20   17:954K
Top
Filing Submission 0001035267-20-000166   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Mon., Apr. 29, 9:59:27.2am ET